Up-regulation of components of the renin-angiotensin system in the bile duct-ligated rat liver

Gastroenterology

Volumn 123, Issue 5, 2002, Pages 1667-1676

  Paizis, Georgina ^a   Cooper, Mark E ^a   Schembri, Josefa M ^a   Tikellis, Christos ^a   Burrell, Louise M ^a   Angus, Peter W ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN RECEPTOR; ANGIOTENSINOGEN; DIPEPTIDYL CARBOXYPEPTIDASE; MESSENGER RNA; RENIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE DUCT LIGATION; CONTROLLED STUDY; DISEASE ASSOCIATION; FIBROGENESIS; GENE EXPRESSION; HEART MUSCLE FIBROSIS; IMMUNOHISTOCHEMISTRY; KIDNEY FIBROSIS; LIVER CELL; LIVER DISEASE; LIVER FIBROSIS; LIVER INJURY; LIVER PARENCHYMA; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECEPTOR BINDING; RECEPTOR GENE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

EID: 0036830185     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/gast.2002.36561     Document Type: Article

References (35)

1. Johnston CI. Tissue angiotensin converting enzyme in cardiac and vascular hypertrophy, repair, and remodeling. Hypertension 1994;23:258-268.
2. Burrell LM, Farina NK, Balding LC, Johnston CI. Beneficial renal and cardiac effects of vasopeptidase inhibition with S21402 in heart failure. Hypertension 2000;36:1105-1111.
3. Cao Z, Cooper ME, Wu LL, Cox AJ, Jandeleit-Dahn K, Kelly DJ, Gilbert RE. Blockade of the renin-angiotensin and endothelin systems on progressive renal injury. Hypertension 2000;36:561-568.
4. Lewis EJ, Hunsicker LG, Clarke WR, Berl T, Pohl MA, Lewis JB, Ritz E, Atkins RC, Rohde R, Raz I. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 2001;345:851-860.
5. Burrell LM, Johnston Cl. Clinical trials of ACE inhibitors: Pathogenetic insights and therapeutic advances. In: Husain A, ed. Drugs, Enzymes, and Receptors of the Renin-Angiotensin System: Celebrating a Century of Discovery. Amsterdam: Harwood, 2000:191-200.
6. Paizis G, Gilbert RE, Cooper ME, Murthi P, Schembri JM, Wu LL, Rumble JR, Kelly DJ, Tikellis C, Cox A, Smallwood RA, Angus PW. Effect of angiotensin II type 1 receptor blockade on experimental hepatic fibrogenesis. J Hepatol 2001;35:376-385.
7. Jonsson JR, Clouston AD, Ando Y, Kelemen LI, Horn MJ, Adamson MD, Purdie DM, Powell EE. Angiotensin-converting enzyme inhibition attenuates the progression of rat hepatic fibrosis. Gastroenterology 2001;121:148-155.
8. Yoshiji H, Kuriyama S, Yoshii J, Ikenaka Y, Noguchi R, Nakatani T, Tsujinoue H, Fukui H. Angiotensin-II type 1 receptor interaction is a major regulator for liver fibrosis development in rats. Hepatology 2001;34:745-750.
9. Kountouras J, Billing BH, Scheuer PJ. Prolonged bile duct obstruction: A new experimental model for cirrhosis in the rat. Br J Exp Pathol 1984;65:305-311.
10. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-159.
11. Sun Y, Mendelsohn FA. Angiotensin converting enzyme inhibition in heart, kidney, and serum studied ex vivo after administration of zofenopril, captopril, and lisinopril. J Cardiovasc Pharmacol 1991;18:478-486.
12. Gilbert RE, Wu LL, Kelly DJ, Cox A, Wilkinson-Berka JL, Johnston Cl, Cooper ME. Pathological expression of renin and angiotensin II in the renal tubule after subtotal nephrectomy. Implications for the pathogenesis of tubulointerstitial fibrosis. Am J Pathol 1999;155:429-440.
13. Snedecor GW, Cochran WG. Statistical Methods. 7th Ed. Iowa: Iowa State University Press, 1980:228-236.
14. Katwa LC, Campbell SE, Tyagi SC, Lee SJ, Cicila GT, Weber KT. Cultured myofibroblasts generate angiotensin peptides de novo. J Mol Cell Cardiol 1997;29:1375-1386.
15. Gaillard-Sanchez I, Mattei MG, Clauser E, Corvol P. Assignment by in situ hybridization of the angiotensinogen gene to chromosome band lq4, the same region as the human renin gene. Hum Genet 1990;84:341-343.
16. Kon Y, Endoh D, Yamashita T, Watanabe T. Expression of renin in the rat liver. Anat Histol Embryol 1998;27:111-118.
17. Bataller R, Gines P, Lora J, Sole M, Nicolas J, Jimenez W, Arroyo V, Rodes J. Evidence for a local renin-angiotensin system in human liver: Expression in activated hepatic stellate cells (abstr). Hepatology 2001;34:908.
18. Bataller R, Gines P, Nicolas JM, Gorbig MN, Garcia-Ramallo E, Gasull X, Bosch J, Arroyo V, Rodes J. Angiotensin II induces contraction and proliferation of human hepatic stellate cells. Gastroenterology 2000;118:1149-1156.
19. Rioux KP, Sharkey KA, Wallace JL, Swain MG. Hepatic mucosal mast cell hyperplasia in rats with secondary biliary cirrhosis. Hepatology 1996;23:888-895.
20. Gordon JR, Galli SJ. Promotion of mouse fibroblast collagen gene expression by mast cells stimulated via the Fc epsilon RI. Role for mast cell-derived transforming growth factor β and tumor necrosis factor α. J Exp Med 1994;180:2027-2037.
21. Ramadori G. The stellate cell (Ito-cell, fat-storing cell, lipocyte, perisinusoidal cell) of the liver. New insights into pathophysiology of an intriguing cell. Virchows Arch B Cell Pathol Incl Mol Pathol 1991;61:147-158.
22. Thompson HL, Burbelo PD, Gabriel G, Yamada Y, Metcalfe DD. Murine mast cells synthesize basement membrane components. A potential role in early fibrosis. J Clin Invest 1991;87:619-623.
23. Ikura Y, Ohsawa M, Ogami M, Hishikawa K, Kotani K, Nishio K, Nishiguchi S, Seki S, Oshishi M, Ueda M. Mast cell chymase and tissue renin-angiotensin system in human cirrhotic livers: Possible contribution to liver fibrosis and portal hypertension (abstr). Hepatology 2001;34:183A.
24. Shanmugam S, Lenkei ZG, Gasc JM, Corvol PL, Llorens-Cortes CM. Ontogeny of angiotensin II type 2 (AT2) receptor mRNA in the rat. Kidney Int 1995;47:1095-1100.
25. Nio Y, Matsubara H, Murasawa S, Kanasaki M, Inada M. Regulation of gene transcription of angiotensin II receptor subtypes in myocardial infarction. J Clin Invest 1995;95:46-54.
26. Bonnet F, Cooper ME, Carey RM, Casley D, Cao Z. Vascular expression of angiotensin type 2 receptor in the adult rat: Influence of angiotensin II infusion. J Hypertens 2001;19:1075-1081.
27. Matsubara H. Pathophysiological role of angiotensin Il type 2 receptor in cardiovascular and renal diseases. Circ Res 1998;83:1182-1191.
28. Dzau VJ, Bernstein K, Celermajer D, Cohen J, Dahlof B, Deanfield J, Diez J, Drexler H, Ferrari R, van Gilst W, Hansson L, Hornig B, Husain A, Johnston C, Lazar H, Lonn E, Luscher T, Mancini J, Mimran A, Pepine C, Rabelink T, Remme W, Ruilope L, Ruzicka M, Schunkert H, Swedberg K, Unger T, Vaughan D, Weber M. The relevance of tissue angiotensin-converting enzyme: Manifestations in mechanistic and endpoint data. Am J Cardiol 2001;88:1L-20L.
29. Dzau VJ. Theodore Cooper Lecture: Tissue angiotensin and pathobiology of vascular disease: A unifying hypothesis. Hypertension 2001;37:1047-1052.
30. Sellars L, Shore AC, Wilkinson R, James OF, Robson V. Sodium status and the renin-angiotensin-aldosterone system in compensated liver disease. Eur J Clin Invest 1981;11:299-304.
31. Kondo K, Nakamura R, Saito I, Saruta T, Matsuki S. Renin, angiotensin II, and juxtaglomerular apparatus in liver cirrhosis. Jpn Circ J 1974;38:913-921.
32. Duncan AM, Burrell LM, Kladis A, Campbell DJ. Angiotensin and bradykinin peptides in rats with myocardial infarction. J Card Fail 1997;3:41-52.
33. Passier RC, Smits JF, Verluyten MJ, Daemen MJ. Expression and localization of renin and angiotensinogen in rat heart after myocardial infarction. Am J Physiol 1996;271:H1040-H1048.
34. Cao Z, Cooper ME. Role of angiotensin II in tubulointerstitial injury. Semin Nephrol 2001;21:554-62.
35. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The heart outcomes prevention evaluation study investigators. N Engl J Med 2000;342:145-153.